NCT06472934View on ClinicalTrials.gov

Impact of Beta-blocker on Outcome Among Patients Undergoing Transcatheter Aortic Valve Replacement (B-TAVR)

NARecruitingINTERVENTIONAL
Enrollment

498

Participants

Timeline

Start Date

July 4, 2024

Primary Completion Date

May 31, 2028

Study Completion Date

May 31, 2028

Conditions
Aortic Stenosis
Interventions
OTHER

Transcatheter aortic valve replacement in the absence of B-blocker treatment

Transcatheter aortic valve replacement (TAVR) is performed in patients that temporarily pause B-blocker treatment.

OTHER

Transcatheter aortic valve replacement

Transcatheter aortic valve replacement (TAVR) is performed in patients that do not temporarily pause B-blocker treatment.

Trial Locations (4)

1205

RECRUITING

Geneva University Hospitals, Geneva

3010

RECRUITING

Inselspital, Bern University Hospital, Bern

4031

RECRUITING

University Hospital Basel, Basel

8091

RECRUITING

University Hospital of Zürich, Zurich

All Listed Sponsors
lead

University Hospital, Basel, Switzerland

OTHER